| CCR5 deletion protects against inflammation-associated mortality in dialysis patients. | |
| | |
MedLine Citation:
|
PMID: 19389855 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The CC-chemokine receptor 5 (CCR5) is a receptor for various proinflammatory chemokines, and a deletion variant of the CCR5 gene (CCR5 Delta 32) leads to deficiency of the receptor. We hypothesized that CCR5 Delta 32 modulates inflammation-driven mortality in patients with ESRD. We studied the interaction between CCR5 genotype and levels of high-sensitivity C-reactive protein (hsCRP) in 603 incident dialysis patients from the multicenter, prospective NEtherlands COoperative Study on the Adequacy of Dialysis (NECOSAD) cohort. CCR5 genotype and hsCRP levels were both available for 413 patients. During 5 yr of follow-up, 170 patients died; 87 from cardiovascular causes. Compared with the reference group of patients who had the wild-type CCR5 genotype and hsCRP <or= 10 mg/L (n = 225), those carrying the deletion allele with hsCRP <or= 10 mg/L (n = 55) had similar mortality, and those carrying the wild-type genotype with hsCRP > 10 mg/L (n = 108) had an increased risk for mortality (HR: 1.82; 95% CI: 1.29 to 2.58). However, those carrying the deletion allele with hsCRP > 10 mg/L (n = 25) had a mortality rate similar to the reference group; this seemingly protective effect of the CCR5 deletion was even more pronounced for cardiovascular mortality. We replicated these findings in an independent Swedish cohort of 302 ESRD patients. In conclusion, the CCR5 Delta 32 polymorphism attenuates the adverse effects of inflammation on overall and cardiovascular mortality in ESRD. |
| | |
Authors:
|
Friso L H Muntinghe; Marion Verduijn; Mike W Zuurman; Diana C Grootendorst; Juan Jesus Carrero; Abdul Rashid Qureshi; Karin Luttropp; Louise Nordfors; Bengt Lindholm; Vincent Brandenburg; Martin Schalling; Peter Stenvinkel; Elisabeth W Boeschoten; Raymond T Krediet; Gerjan Navis; Friedo W Dekker |
Related Documents
:
|
19968705 - Predictive value of ankle brachial index in patients with acute ischaemic stroke. 8232105 - Lipid abnormalities and end-stage renal disease: implications for atherosclerotic cardi... 8408935 - Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill... 16187255 - Endothelin-1 levels predict 3-year survival in patients who have amputation for critica... 16399965 - Patient- and facility-level factors associated with diffusion of a new antipsychotic in... 11699225 - Clinical importance of serum vascular endothelial and basic fibroblast growth factors i... |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't Date: 2009-04-23 |
Journal Detail:
|
Title: Journal of the American Society of Nephrology : JASN Volume: 20 ISSN: 1533-3450 ISO Abbreviation: J. Am. Soc. Nephrol. Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-07-01 Completed Date: 2009-07-27 Revised Date: 2013-06-02 |
Medline Journal Info:
|
Nlm Unique ID: 9013836 Medline TA: J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 1641-9 Citation Subset: IM |
Affiliation:
|
University Medical Center Groningen, Department of Internal Medicine, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands. f.l.h.muntinghe@int.umcg.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged C-Reactive Protein / metabolism Cardiovascular Diseases / complications, metabolism Cohort Studies Female Follow-Up Studies Gene Deletion* Humans Inflammation / complications*, metabolism, prevention & control* Kaplan-Meier Estimate Kidney Failure, Chronic / ethnology, mortality*, therapy* Male Middle Aged Netherlands Polymorphism, Genetic / genetics Prospective Studies Receptors, CCR5 / genetics*, metabolism Renal Dialysis Sweden |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, CCR5; 9007-41-4/C-Reactive Protein |
| Comments/Corrections | |
Comment In:
|
J Am Soc Nephrol. 2009 Jul;20(7):1429-31
[PMID:
19520751
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy.
Next Document: Urine podocyte mRNAs mark progression of renal disease.